Per‐Uno Malmström

12.8k total citations · 2 hit papers
215 papers, 7.9k citations indexed

About

Per‐Uno Malmström is a scholar working on Surgery, Oncology and Urology. According to data from OpenAlex, Per‐Uno Malmström has authored 215 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Surgery, 51 papers in Oncology and 36 papers in Urology. Recurrent topics in Per‐Uno Malmström's work include Bladder and Urothelial Cancer Treatments (163 papers), Urinary and Genital Oncology Studies (109 papers) and Urological Disorders and Treatments (27 papers). Per‐Uno Malmström is often cited by papers focused on Bladder and Urothelial Cancer Treatments (163 papers), Urinary and Genital Oncology Studies (109 papers) and Urological Disorders and Treatments (27 papers). Per‐Uno Malmström collaborates with scholars based in Sweden, United States and United Kingdom. Per‐Uno Malmström's co-authors include Erkki Rintala, Kenneth Wester, Christer Busch, Yair Lotan, Ashish M. Kamat, Noah M. Hahn, Jason A. Efstathiou, Seth P. Lerner, Woonyoung Choi and Charles C. Guo and has published in prestigious journals such as The Lancet, PLoS ONE and Analytical Chemistry.

In The Last Decade

Per‐Uno Malmström

207 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bladder cancer

2016 1.0k citations Per‐Uno Malmström et al. profile →
An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

2009 465 citations Per‐Uno Malmström, J. Alfred Witjes et al. European Urology profile →

Peers

Countries citing papers authored by Per‐Uno Malmström

Since Specialization

Citations

This map shows the geographic impact of Per‐Uno Malmström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per‐Uno Malmström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per‐Uno Malmström more than expected).

Fields of papers citing papers by Per‐Uno Malmström

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per‐Uno Malmström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per‐Uno Malmström. The network helps show where Per‐Uno Malmström may publish in the future.

Co-authorship network of co-authors of Per‐Uno Malmström

This figure shows the co-authorship network connecting the top 25 collaborators of Per‐Uno Malmström. A scholar is included among the top collaborators of Per‐Uno Malmström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per‐Uno Malmström. Per‐Uno Malmström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer: A Nationwide Population-based Study 2024 ·European Urology Oncology ·Fredrik Liedberg, Truls Gårdmark, Oskar Hagberg, Firas Aljabery, Viveka Ströck, Abolfazl Hosseini, Per‐Uno Malmström, Karin Söderkvist, Anders Ullén, (unknown), Staffan Jahnson, Lars Holmberg, Christel Häggström	1
2	Short term outcomes after robot assisted and open cystectomy - A nation-wide population-based study 2023 ·European Journal of Surgical Oncology ·Oskar Bergengren, (unknown), Anna Bill‐Axelson, Hans Garmo, Oskar Hagberg, Firas Aljabery, Truls Gårdmark, Staffan Jahnson, (unknown), Per‐Uno Malmström, Amir Sherif, Viveka Ströck, Karin Söderkvist, Anders Ullén, Lars Holmberg, Christel Häggström, Fredrik Liedberg	4
3	Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer 2023 ·BMC Cancer ·(unknown), (unknown), Polat Türker, Per‐Uno Malmström, (unknown), Artur Mezheyeuski, Douglas G. Ward, Richard T. Bryan, Ulrika Segersten, Martin Lord, Sara M. Mangsbo	7
4	Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0 2022 ·BMJ Open ·Christel Häggström, Oskar Hagberg, Truls Gårdmark, Firas Aljabery, Viveka Ströck, Abolfazl Hosseini, Amir Sherif, Per‐Uno Malmström, Karin Söderkvist, Anders Ullén, (unknown), Staffan Jahnson, Fredrik Liedberg, Lars Holmberg	8
5	Thromboembolism in Muscle-Invasive Bladder Cancer. A Population-based Nationwide Study 2021 ·Bladder Cancer ·Staffan Jahnson, Truls Gårdmark, Abolfazl Hosseini, (unknown), Fredrik Liedberg, Per‐Uno Malmström, Oskar Hagberg, Amir Sherif, Viveka Ströck, Karin Söderkvist, Anders Ullén, Christel Häggström, Lars Holmberg, Firas Aljabery	1
6	A Nationwide Population Based Analysis of Organ-Confined Muscle-Invasive Bladder Cancer Patients Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014. 2019 ·The Journal of Urology ·(unknown), Truls Gårdmark, Lars Lindhagen, Albert Chau, Per‐Uno Malmström	1
7	No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study 2019 ·World Journal of Urology ·(unknown), Ruoqing Chen, Fredrik Liedberg, Ove Andrén, Viveka Ströck, Firas Aljabery, Abolfazl Hosseini, Amir Sherif, Per‐Uno Malmström, Anders Ullén, Truls Gårdmark, Katja Fall	18
8	Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options? 2019 ·European Urology Oncology ·Morgan Rouprêt, Per‐Uno Malmström, Peter C. Black	2
9	Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe) 2017 ·BMJ Open ·Christel Häggström, Fredrik Liedberg, Oskar Hagberg, Firas Aljabery, Viveka Ströck, Abolfazl Hosseini, Truls Gårdmark, Amir Sherif, Per‐Uno Malmström, Hans Garmo, Staffan Jahnson, Lars Holmberg	40
10	EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides 2014 ·Radiology and Oncology ·Jörgen Carlsson, Kenneth Wester, Manuel de la Torre, Per‐Uno Malmström, Truls Gårdmark	41
11	Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle–Invasive Bladder Cancer 2012 ·American Journal Of Pathology ·Niels Fristrup, Karin Birkenkamp‐Demtröder, Thomas Reinert, Marta Sänchez‐Carbayo, Ulrika Segersten, Per‐Uno Malmström, Joan Palou, M. Álvarez-Múgica, Chin‐Chen Pan, Benedicte Parm Ulhøi, Michael Borre, Torben F. Ørntoft, Lars Dyrskjøt	67
12	AdCD40L Immunogene Therapy for Bladder Carcinoma—The First Phase I/IIa Trial 2010 ·Clinical Cancer Research ·Per‐Uno Malmström, Angelica Loskog, (unknown), Sara M. Mangsbo, Moa Fransson, Alkwin Wanders, Truls Gårdmark, Thomas H. Tötterman	84
13	Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study 2007 ·Clinical Cancer Research ·Lars Dyrskjøt, Karsten Zieger, Francisco X. Real, Núria Malats, Alfredo Carrato, Carolyn D. Hurst, (unknown), Margaret A. Knowles, Per‐Uno Malmström, Manuel de la Torre, Kenneth Wester, Yves Allory, Dimitri Vordos, Aurélie Caillault, François Radvanyi, Anne-Mette K. Hein, Jens Ledet Jensen, Klaus Møller‐Ernst Jensen, Niels Marcussen, Torben F. Ørntoft	154
14	In Vitro Evaluation of Two Polyhedral Boron Anion Derivatives as Linkers for Attachment of Radioiodine to the Anti-HER2 Monoclonal Antibody Trastuzumab 2007 ·Cancer Biotherapy and Radiopharmaceuticals ·Mikael Persson, Igor B. Sivaev, (unknown), Lars Gedda, Per‐Uno Malmström, Vladimir Tolmachev	3
15	Prediction of recurrence in Ta urothelial cell carcinoma by real‐time quantitative PCR analysis: A microarray validation study 2006 ·International Journal of Cancer ·Iman J. Schultz, Kenneth Wester, Huub Straatman, Lambertus A. Kiemeney, Marko Babjuk, Jaroslav Mareš, (unknown), Dorine W. Swinkels, J. Alfred Witjes, Jacques B de Kok, Per‐Uno Malmström	19
16	Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases 2005 ·British Journal of Urology ·Truls Gårdmark, Kenneth Wester, Manuel de la Torre, Jörgen Carlsson, Per‐Uno Malmström	47
17	Guidelines on Bladder Cancer 2002 ·European Urology ·Willem Oosterlinck, Bernard Lobel, G. Jakse, Per‐Uno Malmström, Michael Stöckle, Cora N. Sternberg	360
18	Expression of epidermal growth factor receptor in urinary bladder cancer metastases 1998 ·International Journal of Cancer ·(unknown), Kenneth Wester, Anna Sjöström, Anders Holmberg, Sten Nilsson, Jörgen Carlsson, Jan‐Erik Westlin, Christer Busch, Per‐Uno Malmström	1
19	Expression of epidermal growth factor receptor in urinary bladder cancer metastases 1998 ·International Journal of Cancer ·(unknown), Kenneth Wester, (unknown), Anders Holmberg, Sten Nilsson, Jörgen Carlsson, Jan‐Erik Westlin, Christer Busch, Per‐Uno Malmström	41
20	Toward an objective method of mitotic figure counting and its prognostic significance in bladder cancer. 1995 ·Janos Vasko, Per‐Uno Malmström, Adam Taube, Kenneth Wester, C. Busch	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact